India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks

Credit: DNA- Published on September 22, 2020
Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy`s, told Reuters.

You are here


💡 newsR Knowledge: Other News Mentions

Gam-COVID-Vac

Viral vector vaccine candidate based on human adenovirus
After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian..
Credit: IndiaTimes - Published 2 days ago


Related videos from verified sources

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines 05:47
Credit: HT Digital Content - Published 2 days ago 


J&J pauses Covid vaccine trial after unexplained illness | Oneindia News 01:16
Credit: Oneindia - Published 1 week ago 


Covid-19: India declines proposal to test Sputnik-V Covid-19 vaccine in a large study |Oneindia News 01:16
Credit: Oneindia - Published 2 weeks ago 


You might like